How should Group A Streptococcus (Streptococcus pyogenes) and Group B Streptococcus (Streptococcus agalactiae) isolated from a urine culture be interpreted and treated in pregnant versus non‑pregnant patients?

Management of Group A and B Streptococcus in Urine Culture

Pregnant Patients: Treat ALL Group B Streptococcus Bacteriuria Immediately and Provide Intrapartum Prophylaxis

Any concentration of GBS isolated from urine during pregnancy mandates immediate treatment of the urinary infection plus mandatory intravenous intrapartum antibiotic prophylaxis during labor, regardless of symptoms, colony count, or whether the UTI was previously treated. 1, 2

Why This Matters in Pregnancy

• GBS bacteriuria at any concentration is a marker for heavy genital tract colonization and significantly increases the risk of early-onset neonatal GBS disease 29-fold compared to non-colonized mothers 1, 2
• Treating the acute UTI during pregnancy does not eliminate GBS colonization from the genitourinary tract—recolonization after oral antibiotics is typical, which is why intrapartum IV prophylaxis remains mandatory even if bacteriuria was treated earlier 2, 3
• Pregnant women with documented GBS bacteriuria should not undergo routine vaginal-rectal screening at 35–37 weeks because they are presumed heavily colonized and automatically qualify for intrapartum prophylaxis 1, 3

Treatment Protocol for Pregnant Patients

Immediate UTI Treatment:

• Treat the acute symptomatic UTI according to standard pregnancy UTI protocols using pregnancy-safe antibiotics based on susceptibility testing 2

Mandatory Intrapartum Prophylaxis (During Labor):

• First-line (no penicillin allergy): Penicillin G 5 million units IV initially, then 2.5–3.0 million units IV every 4 hours until delivery 1, 2
• Alternative (no penicillin allergy): Ampicillin 2 g IV initially, then 1 g IV every 4 hours until delivery 1, 2
• Low-risk penicillin allergy (no anaphylaxis, angioedema, respiratory distress, or urticaria): Cefazolin 2 g IV initially, then 1 g IV every 8 hours until delivery 1, 2
• High-risk penicillin allergy: Obtain clindamycin and erythromycin susceptibility testing immediately 1, 2
  • If susceptible to both: Clindamycin 900 mg IV every 8 hours until delivery 1, 2
  • If resistant or unknown: Vancomycin 1 g IV every 12 hours until delivery 1, 2

Critical Timing

• Administer intrapartum prophylaxis at least 4 hours before delivery for maximum effectiveness—this achieves 78% reduction in early-onset neonatal GBS disease 1, 2
• For women presenting with preterm labor (<37 weeks) and GBS bacteriuria, start GBS prophylaxis immediately at hospital admission 2

Common Pitfall to Avoid

Never treat asymptomatic GBS vaginal colonization with oral or IV antibiotics before labor—such treatment is completely ineffective at eliminating carriage, promotes antibiotic resistance, and offers no clinical benefit 1, 2

---

Non-Pregnant Patients: Treat Only If Symptomatic or High-Risk

In non-pregnant adults, GBS bacteriuria should be treated only when the patient has urinary symptoms (dysuria, frequency, urgency, suprapubic pain) or underlying urinary tract abnormalities—asymptomatic bacteriuria should NOT be treated. 3, 4

When to Treat in Non-Pregnant Patients

• Symptomatic UTI with classic urinary symptoms (dysuria, frequency, urgency, suprapubic pain, flank tenderness) 4
• Underlying urinary tract abnormalities (chronic renal failure, structural abnormalities, recurrent UTIs) 5
• Scheduled endoscopic urologic procedure involving mucosal trauma 4

When NOT to Treat in Non-Pregnant Patients

• Asymptomatic bacteriuria in otherwise healthy adults 3, 4
• Nonspecific symptoms alone (malaise, fatigue, confusion) without urinary symptoms 4
• Elderly or institutionalized individuals with only nonspecific symptoms 4
• Patients with indwelling catheters (short-term or long-term) unless symptomatic 4
• Patients with diabetes mellitus who are asymptomatic 4

Evidence Against Treating Asymptomatic Bacteriuria

• Treating asymptomatic bacteriuria leads to unnecessary antibiotic exposure, promotes antimicrobial resistance, increases risk of Clostridioides difficile infection, and causes adverse drug effects without measurable clinical benefit 4
• In hospitalized patients with asymptomatic bacteriuria and delirium, antimicrobial treatment did not improve outcomes and was associated with worse functional recovery 4

Treatment Regimens for Symptomatic Non-Pregnant Patients

• First-line: Penicillin G 500 mg orally every 6–8 hours for 7–10 days 4
• Alternative: Ampicillin 500 mg orally every 8 hours for 7–10 days 4
• Penicillin allergy: Clindamycin 300–450 mg orally every 8 hours (with susceptibility testing due to 13–25% resistance) 4, 6
• Complicated infections or suspected prostatitis in men: Extend treatment to 14 days 4
• Severe presentations or complicated UTI: Consider initial IV ampicillin 2 g IV every 4–6 hours, then transition to oral therapy once clinically stable 4

---

Group A Streptococcus (Streptococcus pyogenes) in Urine

Group A Streptococcus isolated from urine is uncommon and typically represents contamination or secondary infection in the setting of skin/soft tissue infection. 1

Clinical Context

• GAS is a common cause of primary skin and soft tissue infections (cellulitis, impetigo, erysipelas) but is not a typical urinary pathogen 1
• When isolated from urine, consider whether the patient has concurrent skin infection, recent instrumentation, or immunocompromise 1
• GAS is not detected by Group B PCR tests, so laboratories must specifically identify it 1

Treatment Approach

• If symptomatic UTI with GAS: Treat with penicillin or amoxicillin (GAS remains universally susceptible to beta-lactams) 7
• If asymptomatic or likely contamination: Repeat culture and evaluate for alternative sources of infection 1
• Pregnant patients: No specific intrapartum prophylaxis protocol exists for GAS bacteriuria (unlike GBS), but treat symptomatic UTI according to standard protocols 1

---

Key Laboratory Considerations

• Laboratories should report GBS in urine when present at concentrations ≥10,000 CFU/mL (≥10⁴ CFU/mL) 1, 3
• Clinicians must inform laboratories when submitted urine specimens are from pregnant women to ensure proper testing and reporting 1
• For pregnant patients with high-risk penicillin allergy, susceptibility testing for clindamycin and erythromycin should be ordered immediately, including D-zone testing for inducible clindamycin resistance 1, 2

---

Critical Pitfalls Summary

• Never assume treating a UTI in pregnancy eliminates the need for intrapartum prophylaxis—this is a common and dangerous error 2
• Never treat asymptomatic GBS colonization (vaginal or urinary) with antibiotics before labor in pregnant women—it is ineffective and harmful 1, 2
• Never treat asymptomatic bacteriuria in non-pregnant adults—it causes harm without benefit 3, 4
• Never use clindamycin empirically without susceptibility testing—resistance rates range from 13–25% 2, 6